Xyntha Kit
Product Images NDC 58394-014

Product Visual Gallery

This gallery contains 46 technical images submitted to the FDA as part of the official labeling for Xyntha (NDC 58394-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Xyntha 01)

An instructional illustration showing a hand gripping and twisting the cap of a vial or similar container, with an arrow indicating the direction to twist or open it.*

FDA Label Image

Figure (Xyntha 02)

An instructional illustration showing a vial and a stopper with a downward arrow indicating the action of pressing or inserting the stopper onto the vial, likely related to the preparation or assembly of the Xyntha antihemophilic factor (recombinant) kit by Wyeth BioPharma Division.*

FDA Label Image

Figure (Xyntha 03)

An instructional illustration showing hands assembling or preparing a medical syringe and vial, indicating steps to remove a cap and connect components, likely related to kit use instructions for Xyntha (antihemophilic factor recombinant).*

FDA Label Image

Figure (Xyntha 04)

An instructional illustration showing hands preparing two vial stoppers by removing caps, likely demonstrating the initial steps for reconstituting or using the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 05)

An instructional illustration showing a hand pulling off the cap from the top of a vial or bottle. The image likely demonstrates the step to remove the vial cap before accessing its contents, relevant to preparation or usage steps for the product kit.*

FDA Label Image

Figure (Xyntha 06)

An instructional diagram depicting a step-by-step process to connect a vial and a syringe or vial adapter. It shows a vial on the bottom and an inverted vial with an attached cap or stopper above it, suggesting a preparation or reconstitution method.*

FDA Label Image

Figure (Xyntha 07)

An instructional illustration showing a hand holding a syringe connected to a vial or container with an arrow indicating downward movement, likely demonstrating preparation or mixing steps involved with the Xyntha kit, antihemophilic factor (recombinant).*

FDA Label Image

Figure (Xyntha 08)

Illustration showing hands preparing a syringe by connecting it to a vial, indicating an injection or medication preparation step. No text visible.*

FDA Label Image

Figure (Xyntha 09)

An instructional illustration showing a hand holding a syringe or vial, preparing for injection into the arm. The image likely depicts the administration technique related to the medication Xyntha, antihemophilic factor (recombinant), in kit form.*

FDA Label Image

Figure (Xyntha 10)

An instructional illustration showing a hand holding a vial and a syringe connected by tubing, representing preparation or administration steps for a medication kit.*

FDA Label Image

Figure (Xyntha 11)

An instructional line drawing showing two hands preparing medication by removing a cap from a vial and holding a syringe. This illustration suggests steps for medication reconstitution or injection preparation, related to the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 12)

An instructional illustration showing hands holding a syringe and vial, demonstrating the step of pulling up the syringe plunger to withdraw liquid medication. The diagram consists of two panels, the left panel showing the plunger being pulled back and the right panel showing the syringe with liquid inside.*

FDA Label Image

Figure (Xyntha 13)

An instructional illustration showing two hands assembling a syringe with a vial or adapter, indicating a twisting or turning motion to connect the parts. The image provides a step in the preparation of an injection, likely for the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 14)

An instructional illustration showing hands preparing a syringe or needle by attaching it to a vial or container. The image depicts the action of pushing a syringe downward into the vial with an arrow indicating the direction. This diagram is likely part of medication preparation guidance for Xyntha, an antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 15)

An instructional black-and-white line drawing showing two hands preparing medication. One hand holds a vial, and the other hand inserts a syringe needle into the vial with an arrow indicating upward movement, suggesting the vial is being opened or accessed for fluid withdrawal.*

FDA Label Image

Figure (Xyntha 16)

An instructional line drawing showing hands connecting a syringe to a vial, likely demonstrating preparation or reconstitution of medication. The illustration includes arrows indicating the direction for attachment. No text is visible.*

FDA Label Image

Figure (Xyntha 17)

Instructional illustration showing a hand holding a syringe above a vial, with an arrow indicating the direction to insert or draw liquid from the vial. This diagram likely depicts a step in preparing an injection, associated with the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 18)

An instructional illustration showing a hand holding a vial with the thumb poised to lift the vial cap upward. This image likely demonstrates a step in preparing a medication.*

FDA Label Image

Figure (Xyntha 19)

An instructional illustration showing a vial positioned below a device or cap with an arrow pointing downward, suggesting a step in medication preparation or reconstitution for an injectable product.*

FDA Label Image

Figure (Xyntha 20)

An instructional illustration showing the process of connecting two components, possibly a vial and a syringe, by aligning and twisting to attach. The image uses arrows to indicate the direction of motion for proper assembly.*

FDA Label Image

Figure (Xyntha 21)

An instructional black-and-white line drawing showing two hands holding medical components. One hand is holding a vial or syringe, and the other hand is positioned to connect or twist the components together, indicated by arrows and motion lines reflecting assembly or connection steps.*

FDA Label Image

Figure (Xyntha 22)

An instructional diagram showing a hand pointing or touching the top of a vial with a cap and a stopper, with an upward arrow indicating a step or action to be taken with the vial, likely part of a medication preparation process for the Xyntha antihemophilic factor (recombinant) kit.*

FDA Label Image

Figure (Xyntha 23)

Illustration showing the assembly of a kit for reconstituting a medication. The image depicts a vial with a cap removed and a syringe or dropper above it, indicating the process of adding diluent to the vial, likely part of the Xyntha antihemophilic factor (recombinant) kit by Wyeth BioPharma Division.*

FDA Label Image

Figure (Xyntha 24)

Instructional illustration showing a hand holding a syringe, aligning it vertically downward to connect or insert it into an adapter or vial below, possibly part of the preparation or administration process for Xyntha, an antihemophilic factor recombinant kit by Wyeth BioPharma.*

FDA Label Image

Figure (Xyntha 25)

An instructional diagram illustrating the use of a syringe and vial, showing a hand holding the plunger and another holding the vial stopper with a downward arrow, likely demonstrating how to draw up medication. The image is simple and monochromatic, and does not show any product labeling.*

FDA Label Image

Figure (Xyntha 26)

An instructional illustration showing a hand wiping the inner side of a forearm with a cloth or swab, demonstrating a preparatory step for an injection or blood draw.*

FDA Label Image

Figure (Xyntha 27)

An instructional illustration showing a hand holding a syringe with a needle inserted into a vial or tubing, possibly demonstrating injection or preparation technique related to the Xyntha kit. The diagram includes a connected tube and a clamp, indicating a step in the medication administration process.*

FDA Label Image

Figure (Xyntha 28)

An instructional illustration showing a syringe being disposed of into a sharps container marked with a biohazard symbol. The image depicts safe syringe disposal practices, often included in medication or medical kit instructions.*

FDA Label Image

Figure (Xyntha 29)

An instructional line drawing showing hands preparing a syringe by attaching it to a vial. The illustration depicts the step of drawing medication from the vial into the syringe, likely indicating part of the preparation process for Xyntha, an antihemophilic factor (recombinant) kit by Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC.*

FDA Label Image

Figure (Xyntha 30)

An instructional illustration showing two hand positions for handling a syringe. The left image demonstrates holding the syringe with fingers gripping the barrel and the thumb below, with an arrow indicating upward movement. The right image shows a different grip with fingers and thumb holding the syringe horizontally. This likely relates to proper syringe use for the Xyntha kit.*

FDA Label Image

Figure (Xyntha 31)

An instructional illustration showing two hands assembling a syringe and vial. One hand holds the syringe, and the other holds the vial, with an arrow indicating a twisting or attaching motion. This image likely depicts part of the preparation process for administering medication.*

FDA Label Image

Figure (Xyntha 32)

An instructional line drawing showing hands attaching a syringe to a vial or container. The illustration indicates the syringe is being pushed downward onto the vial, suggesting an assembly or preparation step for injection or reconstitution of a medication.*

FDA Label Image

Figure (Xyntha 33)

An instructional illustration showing a hand holding a syringe and inserting its tip into a vial, while the other hand stabilizes the vial. The image demonstrates the process of drawing medication from the vial, likely related to the Xyntha antihemophilic factor (recombinant) kit preparation.*

FDA Label Image

Figure (Xyntha 34)

An instructional illustration showing hands assembling or preparing a syringe by attaching it to a vial, demonstrating how to mix or draw liquid medication from the vial using the syringe. No text or product-specific details are visible.*

FDA Label Image

Figure (Xyntha 35)

An instructional line drawing showing two hands using a syringe to withdraw or mix medication from a vial. One hand holds the vial upside down, while the other hand pushes the plunger of the syringe down, with a downward arrow indicating the direction of movement.*

FDA Label Image

Logo (Xyntha 36)

An instructional illustration showing a syringe being disposed of into a biohazard sharps container, indicated by the biohazard symbol on the container. The image visually directs proper disposal of the syringe after use, relevant to injection-related products like Xyntha, an antihemophilic factor recombinant kit.*

FDA Label Image

Principal Display Panel (4ML VIAL LABEL)

FDA Label Image

Principal Display Panel (250 IU Label)

Label for a 0.9% Sodium Chloride Diluent, 4 mL disposable syringe used as a drug diluent with Xyntha (antihemophilic factor recombinant) kits. The label includes manufacturer and distributor information: Wyeth Pharmaceuticals LLC, a Pfizer subsidiary, and Vetter Pharma-Fertigung GmbH & Co. KG in Germany. The label features a barcode, QR code, and Pfizer logo.*

FDA Label Image

Principal Display Panel (Kit Carton)

Label for Xyntha 250 IU range, an antihemophilic factor (recombinant) kit. The label shows product name, dosage strength, and highlights use for Factor VIII replacement. It includes manufacturer information for Wyeth Pharmaceuticals LLC, storage instructions, and a QR code. The label also features the Pfizer logo and states it is for prescription use only.*

FDA Label Image

Principal Display Panel (500 IU)

Packaging label for Xyntha antihemophilic factor (recombinant) kit, a plasma derivative for intravenous administration. The label indicates a 250 IU range potency and states the product is for Factor VIII replacement therapy only. Manufacturer is Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The kit includes a single vial, pre-filled diluent syringe, and other components with various country origins noted.*

FDA Label Image

Principal Display Panel (Kit Carton)

Label for Xyntha 500 IU Range, antihemophilic factor (recombinant) in kit dosage form, manufactured by Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC. The label indicates single-use with no preservatives, storage instructions at 2° to 8°C, and includes Pfizer branding. The label highlights Factor VIII replacement therapy.*

FDA Label Image

Principal Display Panel (1000 IU)

Packaging label for Xyntha 500 IU range kit containing antihemophilic factor (recombinant) for intravenous administration. The label indicates it is for Factor VIII replacement therapy only and is manufactured by Wyeth Pharmaceuticals, a Pfizer subsidiary. The kit includes a single-use vial and a pre-filled diluent syringe, with additional reconstitution supplies noted. Storage instructions and manufacturing locations are also detailed on the label.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Xyntha 1000 IU Range, an antihemophilic factor (recombinant) kit by Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC. The label states the product contains no preservatives, is for single use, and is intended for Factor VIII replacement. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F). The label includes a QR code, Pfizer logo, and a barcode.*

FDA Label Image

Principal Display Panel (2000 IU)

Packaging label for Xyntha Antihemophilic Factor (Recombinant) 1000 IU Range kit by Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC. The label indicates it is for intravenous administration and for Factor VIII replacement therapy only. The kit contains one vial of sterile Xyntha, one pre-filled diluent syringe, vial adapter, infusion set, alcohol swabs, bandage, gauze, and package insert. Multiple manufacturing locations are noted for components within the kit.*

FDA Label Image

Principal Display Panel (Kit Carton)

Xyntha 2000 IU Range packaging label for antihemophilic factor (recombinant) kit. The label includes the proprietary and generic names, dosage strength, manufacturer Wyeth Pharmaceuticals LLC, storage instructions to refrigerate at 2° to 8°C, and a note indicating it is for Factor VIII replacement. It also displays lot and expiration placeholders, a QR code, and the Pfizer logo with Rx only status.*

FDA Label Image

Xyntha 46

Packaging label for Xyntha Antihemophilic Factor (Recombinant) 2000 IU Range kit for intravenous administration. The label states it is for Factor VIII Replacement Therapy Only. The product is manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The kit contains one vial of sterile Xyntha and a pre-filled diluent syringe, among other components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.